+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automatic Nucleic Acid Synthesizer Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Automatic Nucleic Acid Synthesizer Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Automatic Nucleic Acid Synthesizer Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6080228
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The automatic nucleic acid synthesizer market stands at the forefront of molecular science, enabling precise and efficient creation of DNA, RNA, and peptide sequences. As research institutions and industrial laboratories increasingly demand high-throughput and scalable synthesis solutions, the landscape has evolved to accommodate both standardized processes and bespoke applications. This executive summary delves into the market’s current dynamics, spotlighting critical drivers, emerging challenges, and the transformative innovations shaping tomorrow’s workflows. By engaging with the key technological advances and stakeholder priorities, decision-makers can align strategic initiatives with evolving scientific needs. The insights presented here lay a solid foundation for understanding how automated platforms streamline discovery, accelerate development, and foster a new era of personalized research.

Transitioning from a traditional labor-intensive workflow to fully automated systems requires a clear view of the market’s underlying structure. This introduction frames the subsequent analysis, ensuring that readers appreciate both the granular operational improvements and the broader strategic implications. As you explore the following sections, you will gain clarity on tariff impacts, segmentation nuances, regional variations, competitive dynamics, and actionable recommendations for sustained leadership in this critical sector.

Transformative Shifts Reshaping Synthesis Workflows

In recent years, the integration of microfluidics, cloud-native software, and artificial intelligence has reshaped how laboratories approach nucleic acid synthesis. Analytical instruments now leverage real-time quality control algorithms to minimize error rates, while modular hardware designs permit rapid customization of synthesis protocols. Simultaneously, the push toward decentralized manufacturing has encouraged benchtop synthesizers that cater to both academic settings and emerging biotech startups.

Another shift arises from increased demand for oligonucleotide-based therapeutics, driving higher throughput and precision requirements. Innovators are responding with hybrid and solution-phase synthesis technologies that optimize reagent consumption and shorten cycle times. Moreover, the convergence of genomic and proteomic research has prompted the development of peptide synthesizers that integrate seamlessly with downstream analytical platforms.

Collectively, these transformations underscore a market in flux-one defined by technological convergence, a growing emphasis on automation, and the strategic imperative to deliver reproducible, high-quality biomolecules at scale. Looking ahead, sustaining competitive advantage will hinge on the ability to harness these shifts and deliver end-to-end solutions that address both current research demands and future applications.

Cumulative Impact of US Tariffs in 2025

The introduction of new US tariff measures in 2025 presents a multifaceted challenge for equipment manufacturers and end users. Increased import duties on electronic components and specialty reagents have resulted in higher production costs for synthesizer hardware. At the same time, reagent suppliers face added burdens that trickle down to end users, elevating per-reaction expenses and stretching R&D budgets.

These tariff pressures have prompted several strategic responses. Some original equipment manufacturers are exploring regional assembly hubs to mitigate import duties, while reagent providers are optimizing supply chains to secure preferential trade terms. End users, particularly in academic and research institutes, are re-evaluating maintenance contracts and considering equipment leasing as a flexible alternative to direct capital investment.

Despite these headwinds, the market demonstrates resilience through collaborative procurement strategies and the adoption of open-platform architectures that accommodate locally sourced reagents. By anticipating further policy shifts and proactively adjusting sourcing strategies, stakeholders can attenuate cost escalations and preserve ongoing innovation. Ultimately, understanding the cumulative impact of these tariffs is critical to formulating robust operational plans that safeguard both scientific progress and financial performance.

Key Segmentation Insights Across Multiple Dimensions

Segmenting the nucleic acid synthesizer market through multiple lenses reveals nuanced growth vectors and unmet opportunities. When classified by product type, the market comprises gene synthesizers-divided into commercial and custom modules-oligonucleotide synthesizers, which include both DNA and RNA configurations, and peptide synthesizers designed for amino acid chain assembly. In terms of application area, the ecosystem encompasses forensic testing (spanning crime scene investigation and DNA profiling), industrial uses in environmental and food & beverage testing, pharmaceutical and biotechnology functions such as drug discovery, molecular diagnostics, and therapeutic development, and research applications in genomic discovery, proteomics, and regenerative medicine.

From an end-user perspective, adoption patterns vary across academic and research institutes, contract research organizations that demand batch scalability, forensic laboratories prioritizing precision, hospitals and diagnostic centers seeking rapid turnaround, and pharmaceutical and biotech enterprises requiring integrated workflows. Technological differentiation further arises along the continuum of hybrid synthesis, solid phase-subdivided into column-based and membrane-based formats-and solution phase, which itself spans batch and continuous flow processes. Component-level insights show hardware segments in automation systems, reagents and consumables, and modular synthesizer units, while software platforms drive protocol automation and data integration. Lastly, synthesis scale ranges from small-scale exploratory production to medium-scale pilot runs and large-scale commercial synthesis.

By aligning product development, marketing efforts, and support services with these interlocking segmentation dimensions, market participants can target high-potential niches and tailor offerings to specific research and industrial pain points.

Key Regional Insights Fueling Growth

Regional distinctions play a pivotal role in shaping both demand and innovation trajectories. In the Americas, robust funding for life sciences and a dense network of biopharma clusters drive rapid adoption of advanced synthesizer platforms. Customers in North America often seek turnkey solutions with end-to-end service agreements, while users in Latin America prioritize cost-effective entry-level systems and localized reagent sourcing.

Across Europe, Middle East & Africa, regulatory harmonization and collaborative research consortia accelerate the rollout of synthesis technologies. European institutions frequently integrate synthesizers into multi-instrument lab ecosystems, emphasizing interoperability and data continuity. In the Middle East, emerging biotech hubs are investing in both academic partnerships and industrial-scale facilities, whereas in Africa, demand centers remain focused on infectious disease surveillance and agricultural genomics.

The Asia-Pacific region exhibits a dual dynamic: established markets such as Japan and Australia drive demand for high-precision, custom synthesis, while developing markets in Southeast Asia and India prioritize affordable automation to expand genomic research capacity. Local manufacturing capabilities and government incentives in China have also spurred growth in solution-phase and hybrid synthesis deployments. Taken together, these regional insights highlight where investment, training, and localized support will yield the greatest returns.

Key Company Insights and Competitive Landscape

Competitive dynamics within the automatic nucleic acid synthesizer market reflect a spectrum of established instrument makers, emerging technology specialists, and integrated life sciences providers. Agilent Technologies, Inc. brings deep analytical expertise and broad reagent portfolios, whereas Bio-Rad Laboratories, Inc. leverages its established molecular biology footprint to offer seamless system integrations. Bioneer Corporation and Bruker Corporation differentiate through niche applications in genomic analysis and microfluidics, respectively. Danaher Corporation and Thermo Fisher Scientific Inc. maintain extensive distribution networks and service infrastructures that underpin customer loyalty.

Eurofins Scientific and PerkinElmer, Inc. are expanding into custom synthesis services and high-throughput screening platforms. GE Healthcare Life Sciences and Illumina, Inc. continue to invest in platform innovations that bridge synthesis with downstream sequencing and diagnostics. Merck KGaA and New England BioLabs, Inc. drive reagent and enzyme development, enhancing overall synthesis fidelity. QIAGEN N.V. focuses on integrated sample-to-data workflows, while Oxford Nanopore Technologies Ltd. pioneers portable and real-time molecular analysis. Takara Bio USA, Inc. broadens its portfolio through strategic partnerships, reinforcing its presence in research and biotherapeutic applications.

Collectively, these companies illustrate a competitive landscape where technology platforms, service ecosystems, and strategic alliances define success. Staying attuned to each player’s strengths can inform partnership, acquisition, and product development strategies.

Actionable Recommendations for Industry Leaders

To capitalize on emerging synthesis trends and mitigate tariff-driven cost pressures, industry leaders should pursue several strategic initiatives. First, forging alliances with regional assembly and reagent providers can reduce regulatory friction and strengthen supply chain resilience. Second, investing in modular, upgradeable hardware designs will future-proof existing installations and encourage customer retention through scalable enhancements. Third, integrating AI-driven quality control modules can accelerate time-to-result and differentiate offerings on performance metrics.

Additionally, building out service portfolios-such as consumable subscription models and predictive maintenance plans-will create recurring revenue streams and deepen client relationships. Leaders should also cultivate collaborative research partnerships focused on high-growth applications like regenerative medicine and RNA-based therapeutics, positioning their platforms at the forefront of cutting-edge science. Finally, adopting transparent pricing frameworks and offering flexible financing or leasing options will address budget constraints in academic and emerging-market segments.

By executing these recommendations in parallel, companies can strengthen market positioning, unlock new revenue channels, and drive sustainable growth across both established and nascent markets.

Conclusion and Future Outlook

The automatic nucleic acid synthesizer market is poised for continued evolution, shaped by technological convergence, policy dynamics, and shifting research priorities. Stakeholders who embrace modular architectures, data-driven process optimization, and collaborative ecosystems will unlock the greatest value. Regional nuances and end-user requirements underscore the need for adaptive strategies, while tariff considerations highlight the importance of supply chain agility.

As the demand for high-quality biomolecules intensifies across forensic, industrial, pharmaceutical, and academic domains, vendors and service providers must balance innovation with affordability. By leveraging insights from segmentation, regional trends, and competitive landscapes, decision-makers can navigate complexity and capture emerging opportunities. In doing so, they will ensure that automated synthesis platforms continue to accelerate discovery and underpin new frontiers in molecular science.

Market Segmentation & Coverage

This research report categorizes the Automatic Nucleic Acid Synthesizer Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Gene Synthesizer
    • Commercial Gene Synthesizer
    • Custom Gene Synthesizer
  • Oligonucleotide Synthesizer
    • DNA Synthesizer
    • RNA Synthesizer
  • Peptide Synthesizer
  • Forensic Testing
    • Crime Scene Investigation
    • DNA Profiling
  • Industrial Applications
    • Environmental Testing
    • Food & Beverage Testing
  • Pharmaceutical & Biotechnology
    • Drug Discovery
    • Molecular Diagnostics
    • Therapeutic Uses
  • Research & Academic
    • Genomic Research
    • Proteomics
    • Regenerative Medicine
  • Academic & Research Institutes
  • CROs (Contract Research Organizations)
  • Forensic Laboratories
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Hybrid Synthesis
  • Solid Phase Synthesis
    • Column-Based
    • Membrane-Based
  • Solution Phase Synthesis
    • Batch Process
    • Continuous Flow Process
  • Hardware
    • Automation Systems
    • Reagents & Consumables
    • Synthesizer Modules
  • Software
  • Large-Scale Synthesis
  • Medium-Scale Synthesis
  • Small-Scale Synthesis

This research report categorizes the Automatic Nucleic Acid Synthesizer Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Automatic Nucleic Acid Synthesizer Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioneer Corporation
  • Bruker Corporation
  • Danaher Corporation
  • Eurofins Scientific
  • GE Healthcare Life Sciences
  • Illumina, Inc.
  • Merck KGaA
  • New England BioLabs, Inc.
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automatic Nucleic Acid Synthesizer Market, by Product Type
8.1. Introduction
8.2. Gene Synthesizer
8.2.1. Commercial Gene Synthesizer
8.2.2. Custom Gene Synthesizer
8.3. Oligonucleotide Synthesizer
8.3.1. DNA Synthesizer
8.3.2. RNA Synthesizer
8.4. Peptide Synthesizer
9. Automatic Nucleic Acid Synthesizer Market, by Application Area
9.1. Introduction
9.2. Forensic Testing
9.2.1. Crime Scene Investigation
9.2.2. DNA Profiling
9.3. Industrial Applications
9.3.1. Environmental Testing
9.3.2. Food & Beverage Testing
9.4. Pharmaceutical & Biotechnology
9.4.1. Drug Discovery
9.4.2. Molecular Diagnostics
9.4.3. Therapeutic Uses
9.5. Research & Academic
9.5.1. Genomic Research
9.5.2. Proteomics
9.5.3. Regenerative Medicine
10. Automatic Nucleic Acid Synthesizer Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. CROs (Contract Research Organizations)
10.4. Forensic Laboratories
10.5. Hospitals & Diagnostic Centers
10.6. Pharmaceutical & Biotechnology Companies
11. Automatic Nucleic Acid Synthesizer Market, by Synthesis Technology
11.1. Introduction
11.2. Hybrid Synthesis
11.3. Solid Phase Synthesis
11.3.1. Column-Based
11.3.2. Membrane-Based
11.4. Solution Phase Synthesis
11.4.1. Batch Process
11.4.2. Continuous Flow Process
12. Automatic Nucleic Acid Synthesizer Market, by Component
12.1. Introduction
12.2. Hardware
12.2.1. Automation Systems
12.2.2. Reagents & Consumables
12.2.3. Synthesizer Modules
12.3. Software
13. Automatic Nucleic Acid Synthesizer Market, by Synthesis Scale
13.1. Introduction
13.2. Large-Scale Synthesis
13.3. Medium-Scale Synthesis
13.4. Small-Scale Synthesis
14. Americas Automatic Nucleic Acid Synthesizer Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Automatic Nucleic Acid Synthesizer Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Automatic Nucleic Acid Synthesizer Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Agilent Technologies, Inc.
17.3.2. Bio-Rad Laboratories, Inc.
17.3.3. Bioneer Corporation
17.3.4. Bruker Corporation
17.3.5. Danaher Corporation
17.3.6. Eurofins Scientific
17.3.7. GE Healthcare Life Sciences
17.3.8. Illumina, Inc.
17.3.9. Merck KGaA
17.3.10. New England BioLabs, Inc.
17.3.11. Oxford Nanopore Technologies Ltd.
17.3.12. PerkinElmer, Inc.
17.3.13. QIAGEN N.V.
17.3.14. Takara Bio USA, Inc.
17.3.15. Thermo Fisher Scientific Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET MULTI-CURRENCY
FIGURE 2. AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET MULTI-LANGUAGE
FIGURE 3. AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMMERCIAL GENE SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CUSTOM GENE SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY DNA SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RNA SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PEPTIDE SYNTHESIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CRIME SCENE INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY DNA PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY THERAPEUTIC USES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENOMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CROS (CONTRACT RESEARCH ORGANIZATIONS), BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HYBRID SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COLUMN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY BATCH PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY CONTINUOUS FLOW PROCESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY AUTOMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIZER MODULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY LARGE-SCALE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY MEDIUM-SCALE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SMALL-SCALE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 108. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 110. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 111. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 112. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 113. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 114. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 116. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 119. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 120. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 122. CANADA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 123. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 125. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 126. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 127. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 128. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 131. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 156. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 172. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 173. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 185. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 187. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 188. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 189. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 190. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 191. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 193. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 196. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 197. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 198. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 199. CHINA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 200. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 202. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 203. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 204. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 205. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 206. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 208. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 211. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 212. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 214. INDIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 215. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 217. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 218. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 230. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 232. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 233. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 234. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 235. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 236. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 238. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 241. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 242. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 243. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 244. JAPAN AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 245. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 260. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 262. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 263. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SOLUTION PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS SCALE, 2018-2030 (USD MILLION)
TABLE 275. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY GENE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 277. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIZER, 2018-2030 (USD MILLION)
TABLE 278. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY RESEARCH & ACADEMIC, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE AUTOMATIC NUCLEIC ACID SYNTHESIZER MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE AUTOMAT

Companies Mentioned

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioneer Corporation
  • Bruker Corporation
  • Danaher Corporation
  • Eurofins Scientific
  • GE Healthcare Life Sciences
  • Illumina, Inc.
  • Merck KGaA
  • New England BioLabs, Inc.
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Reports

Automatic Nucleic Acid Synthesizer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Automatic Nucleic Acid Synthesizer Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
DNA Synthesizer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

DNA Synthesizer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
U.S. Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Oligonucleotides, Equipment/Synthesizer), Application (PCR Primers, Sequencing), End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Oligonucleotides, Equipment/Synthesizer), Application (PCR Primers, Sequencing), End-use, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
Catalyst Screening Synthesizer Market by Product Type (Automated Catalyst Screening Synthesizers, Manual Catalyst Screening Synthesizers), Applications (API Development, Chemical Synthesis, Polymer Synthesis), End-User - Global Forecast 2025-2030 - Product Image

Catalyst Screening Synthesizer Market by Product Type (Automated Catalyst Screening Synthesizers, Manual Catalyst Screening Synthesizers), Applications (API Development, Chemical Synthesis, Polymer Synthesis), End-User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Phosphoramidite - Global Strategic Business Report - Product Image

Phosphoramidite - Global Strategic Business Report

  • Report
  • 69 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.